Fidia Pharma USA Inc
David Dowling is an accomplished professional with extensive experience in pharmaceutical sales and business development. Currently serving as Manager of Managed Markets and Reimbursement at Fidia Pharma since September 2014, Dowling has led the Market Access Team and received the 2019 Certificate of Excellence Award for Market Access. Previous roles include Senior Territory Manager for Device Sales at Fidia Pharma and Business Development Manager at T-Mobile, focusing on HIPAA compliance solutions for healthcare. Additional experience includes work as a Pharmaceutical Sales Specialist at AstraZeneca and Publicis Touchpoint Solutions, where Dowling specialized in promoting various pharmaceutical products to healthcare professionals. Dowling's career began with roles at inVentiv Health and GBC, demonstrating a strong foundation in sales and management. David Dowling holds a Bachelor of Science degree in Business Administration and Management from Rutgers University.
This person is not in the org chart
This person is not in any offices
Fidia Pharma USA Inc
Fidia Pharma USA Inc is a wholly-owned subsidiary of the Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid (HA) market segment. Fidia Pharma USA is focused on continually expanding Fidia’s position in the U.S. and Canadian market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance, establishing a sound strategic presence of Fidia in the US consistently with the Company's mission and strategy pillars. Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as joint healthcare and tissue repair. Fidia Pharma USA Inc is headquartered in Parsippany, NJ.